Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer

BACKGROUND: HER2-positive breast cancers are rare amongst BRCA mutation carriers. No data exist regarding clinicopathological characteristics and prognosis of this subgroup of patients. MATERIALS AND METHODS: Using a retrospective matched cohort design, we collected data from 700 women who were diag...

Descripción completa

Detalles Bibliográficos
Autores principales: Viansone, A., Pellegrino, B., Omarini, C., Pistelli, M., Boggiani, D., Sikokis, A., Uliana, V., Zanoni, D., Tommasi, C., Bortesi, B., Bonatti, F., Piacentini, F., Cortesi, L., Camisa, R., Sgargi, P., Michiara, M., Musolino, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399365/
https://www.ncbi.nlm.nih.gov/pubmed/35970028
http://dx.doi.org/10.1016/j.breast.2022.07.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399365/
https://www.ncbi.nlm.nih.gov/pubmed/35970028
http://dx.doi.org/10.1016/j.breast.2022.07.012

Ejemplares similares